Timing and connectivity in the human somatosensory cortex from single trial mass electrical activity von Ioannides, Andreas A., Kostopoulos, George K., Laskaris, Nikolaos A., Liu, Lichan, Shibata, Tadahiko, Schellens, Marc, Poghosyan, Vahe, Khurshudyan, Ara

Volltext

Streptococcus pneumoniae in saliva of Dutch primary school children von Wyllie, Anne L, Chu, Mei Ling J N, Schellens, Mariëlle H B, van Engelsdorp Gastelaars, Jody, Jansen, Marc D, van der Ende, Arie, Bogaert, Debby, Sanders, Elisabeth A M, Trzciński, Krzysztof

Volltext

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorecta... von Van Cutsem, Eric, Huijberts, Sanne, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan, Elez, Elena, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Yoshino, Takayuki, Wasan, Harpreet, Desai, Jayesh, Ciardiello, Fortunato, Gollerkeri, Ashwin, Christy-Bittel, Janna, Maharry, Kati, Sandor, Victor, Schellens, Jan H M, Kopetz, Scott, Tabernero, Josep

Volltext

Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan von Jonker, Johan W., Smit, Johan W., Brinkhuis, Remco F., Maliepaard, Marc, Beijnen, Jos H., Schellens, Jan H. M., Schinkel, Alfred H.

Volltext

Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material von Diestra, Julio E., Scheffer, George L., Català, Isabel, Maliepaard, Marc, Schellens, Jan H. M., Scheper, Rik J., Germà-Lluch, Jose R., Izquierdo, Miguel A.

Volltext

Subcellular localization and distribution of the Breast Cancer Resistance Protein transporter in normal human tissues von MALIEPAARD, Marc, SCHEFFER, George L, FANEYTE, Ian F, VAN GASTELEN, Margot A, PIJNENBORG, Adriana C. L. M, SCHINKEL, Alfred H, DE VIJVER, Marc J, SCHEPER, Rik J, SCHELLENS, Jan H. M

Volltext

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line von MALIEPAARD, M, VAN GASTELEN, M. A, DE JONG, L. A, PLUIM, D, VAN WAARDENBURG, R. C. A. M, RUEVEKAMP-HELMERS, M. C, FLOOT, B. G. J, SCHELLENS, J. H. M

Volltext

Circumvention of Breast Cancer Resistance Protein (BCRP)-mediated Resistance to Camptothecins in Vitro Using Non-Substrate Drugs or the BCRP Inhibitor GF120918 von MALIEPAARD, Marc, VAN GASTELEN, Margot A, TOHGO, Akiko, HAUSHEER, Frederick H, VAN WAARDENBURG, Robert C. A. M, DE JONG, Laurina A, PLUIM, Dick, BEIJNEN, Jos H, SCHELLENS, Jan H. M

Volltext

Expression of the Breast Cancer Resistance Protein in Breast Cancer von FANEYTE, Ian F, KRISTEL, Petra M. P, MALIEPAARD, Marc, SCHEFFER, George L, SCHEPER, Rik J, SCHELLENS, Jan H. M, VAN DE VIJVER, Marc J

Volltext

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin von TERWOGT, Jetske M, GROENEWEGEN, Gerard, BEIJNEN, Jos H, SCHELLENS, Jan H. M, PLUIM, Dick, MALIEPAARD, Marc, TIBBEN, Matthijs M, HUISMAN, Albert, TEN BOKKEL HUININK, Wim W, SCHOT, Margaret, WELBANK, Helen, VOEST, Emile E

Volltext

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer von Gast, Marie-Christine W., Zapatka, Marc, van Tinteren, Harm, Bontenbal, Marijke, Span, Paul N., Tjan-Heijnen, Vivianne C. G., Knol, Jaco C., Jimenez, Connie R., Schellens, Jan H. M., Beijnen, Jos H.

Volltext

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines von SCHEFFER, G. L, MALIEPAARD, M, DALTON, W. S, SCHELLENS, J. H. M, SCHEPER, R. J, PIJNENBORG, A. C. L. M, VAN GASTELEN, M. A, DE JONG, M. C, SCHROEIJERS, A. B, VAN DER KOLK, D. M, ALLEN, J. D, ROSS, D. D, VAN DER VALK, P

Volltext

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry von HELGASON, Helgi H, ENGWEGEN, Judith Y. M. N, ZAPATKA, Marc, VINCENT, Andrew, CATS, Annemieke, BOOT, Henk, BEIJNEN, Jos H, SCHELLENS, Jan H. M

Volltext

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding von van Brummelen, Emilie M.J., Huisman, Marc C., de Wit-van der Veen, Linda J., Nayak, Tapan K., Stokkel, Marcel P.M., Mulder, Emma R., Hoekstra, Otto S., Vugts, Danielle J., Van Dongen, Guus A.M.S., Verheul, Henk M., Evers, Stefan, Tessier, Jean J. L., Saro, Jose, Schellens, Jan H.M., Menke-van der Houven van Oordt, C. Willemien

Volltext

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorecta... von Van Cutsem, Eric, Huijberts, Sanne, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan, Elez, Elena, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Yoshino, Takayuki, Wasan, Harpreet, Desai, C. Jayesh, Ciardiello, Fortunato, Gollerkeri, Ashwin, Christy-Bittel, Janna, Maharry, Kati, Sandor, Victor, Schellens, Jan Hm, Kopetz, Scott, Tabernero, Josep

Volltext

Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BINI) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC) von Kopetz, Scott, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan AR, Huijberts, Sanne, Schellens, Jan H. M., Elez, Elena, Fakih, Marwan, Montagut Viladot, Clara, Peeters, Marc, Desai, Jayesh, Yoshino, Takayuki, Ciardiello, Fortunato, Wasan, Harpreet Singh, Maharry, Kati, Christy-Bittel, Janna, Gollerkeri, Ashwin, Van Cutsem, Eric, Tabernero, Josep

Volltext

BEACON CRC (binimetinib [BINI], encorafenib [ENCO], and cetuximab [CTX] combined to treat BRAF -mutant metastatic colorectal cancer [mCRC]): A multicenter, randomized, open-label,... von Huijberts, Sanne, Schellens, Jan H. M., Fakih, Marwan, Peeters, Marc, Kopetz, Scott, Grothey, Axel, Van Cutsem, Eric, Wasan, Harpreet Singh, Desai, Jayesh, Ciardiello, Fortunato, Yoshino, Takayuki, Maharry, Kati, Gollerkeri, Ashwin, Tabernero, Josep

Volltext

BEACON CRC study safety lead-in (SLI) in patients with BRAF V600E metastatic colorectal cancer (mCRC): Efficacy and tumor markers von Van Cutsem, Eric, Cuyle, Pieter-Jan, Huijberts, Sanne, Yaeger, Rona, Schellens, Jan H. M., Elez, Elena, Tabernero, Josep, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Desai, Jayesh, Yoshino, Takayuki, Ciardiello, Fortunato, Wasan, Harpreet Singh, Kopetz, Scott, Maharry, Kati, Christy-Bittel, Janna, Gollerkeri, Ashwin, Grothey, Axel

Volltext

Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein: Potential Clinical Implications von SCHELLENS, JAN H.M., MALIEPAARD, MARC, SCHEPER, RIK J., SCHEFFER, GEORGE L., JONKER, JOHAN W., SMIT, JOHAN W., BEIJNEN, JOS H., SCHINKEL, ALFRED H.

Volltext

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding von van Brummelen, Emilie M J, Huisman, Marc C, de Wit-van der Veen, Linda J, Nayak, Tapan K, Stokkel, Marcel P M, Mulder, Emma R, Hoekstra, Otto S, Vugts, Danielle J, Van Dongen, Guus A M S, Verheul, Henk M, Evers, Stefan, Tessier, Jean J L, Saro, Jose, Schellens, Jan H M, Menke-van der Houven van Oordt, C Willemien

Volltext